MATINAS BIOPHARMA, INC.

TARPON SPRINGS, FL · Founded 2011 · CIK 0001577078 · Biotech · Public

Lipid nanocrystal (LNC) platform for intracellular oral delivery of small molecules and oligonucleotides

matinasbiopharma.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$1.0M
1 Form D · May 2013
161 months since last filing
Contracts
—
No federal contracts on record
Patents
24
2 granted · 22 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$1,000,001
Form D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2571NEW HORIZON BIOTECH INC——
2572AMPLION INC.—$1.0M
2573Biosceptre International Ltd—$1.0M
2574MATINAS BIOPHARMA, INC.—$1.0M
2575CURIS INC—$964K
2576SUMOCOR, LLC——
2577Thiogenesis Therapeutics, Corp.—$878K

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 5 related persons
  • George BobotasDirector
  • Herbert ConradDirector
  • Stefano FerrariDirector
  • Jerome JabbourDirector
  • Roelof RongenDirector · Executive Officer

Patents

USPTO · 2 granted of 24
  • OMEGA-3 Pentaenoic Acid Compositions And Methods Of Useapplication
  • OMEGA-3 Pentaenoic Acid Compositions And Methods Of Usegranted
  • Methods Of Administering Compositions Comprising Docosapentaenoic Acidgranted
  • Omega-3 Fatty Acid Formulations for Use as Pharmaceutical Treatmentapplication
  • Methods Of Administering Compositions Comprising Docosapentaenoic Acidapplication
  • Compositions Comprising Docosapentaenoic Acid And Methods Of Useapplication
  • OMEGA-3 Pentaenoic Acid Compositions And Methods Of Useapplication
  • OMEGA-3 Pentaenoic Acid Compositions And Methods Of Useapplication
  • OMEGA-3 Pentaenoic Acid Compositions And Methods Of Useapplication
  • OMEGA-3 Pentaenoic Acid Compositions And Methods Of Useapplication
  • OMEGA-3 Pentaenoic Acid Compositions And Methods Of Useapplication
  • Methods Of Administering Compositions Comprising Docosapentaenoic Acidapplication

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.